MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.rec.2016.05.009

Медицинская библиотека · Revista espanola de cardiologia (English ed.) · 2016

Usefulness of a Cardiovascular Polypill in the Treatment of Secondary Prevention Patients in Spain: A Cost-effectiveness Study.

Barrios Vivencio, Kaskens Lisette, Castellano José María, Cosin-Sales Juan, Ruiz José Emilio, Zsolt Ilonka, Fuster Valentín, Gracia Alfredo

СтатьяПеревод в очереди

Аннотация

INTRODUCTION AND

OBJECTIVES

To estimate the health benefits and cost-effectiveness of a polypill intervention (aspirin 100 mg, atorvastatin 20 mg, ramipril 10 mg) compared with multiple monotherapy for secondary prevention of cardiovascular events in adults with a history of myocardial infarction from the perspective of the Spanish National Health System.

METHODS

An adapted version of a recently published Markov model developed and validated in Microsoft Excel was used to compare the cost-effectiveness of the polypill with that of its combined monocomponents over a 10-year time horizon. The population included in the model had a mean age of 64.7 years; most were male and had a history of myocardial infarction. The input parameters were obtained from a systematic literature review examining efficacy, adherence, utilities, and costs. The results of the model are expressed in events avoided, incremental costs, incremental life years, incremental quality-adjusted life years, and the incremental cost-effectiveness ratio.

RESULTS

Over a 10-year period, use of the cardiovascular polypill instead of its monocomponents simultaneously would avoid 46 nonfatal and 11 fatal cardiovascular events per 1000 patients treated. The polypill would also be a more effective and cheaper strategy. Probabilistic analysis of the base case found a 90.9% probability that the polypill would be a cost-effective strategy compared with multiple monotherapy at a willingness-to-pay of 30 000 euros per quality-adjusted life year.

CONCLUSIONS

The polypill would be a cost-effective strategy for the Spanish National Health System with potential clinical benefits.

Для цитирования: Barrios Vivencio, Kaskens Lisette, Castellano José María, Cosin-Sales Juan, Ruiz José Emilio, Zsolt Ilonka, Fuster Valentín, Gracia Alfredo. Usefulness of a Cardiovascular Polypill in the Treatment of Secondary Prevention Patients in Spain: A Cost-effectiveness Study.. Revista espanola de cardiologia (English ed.). 2016. DOI: 10.1016/j.rec.2016.05.009.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.